Associations between Heat Pain Perception and Opioid Dose among Patients with Chronic Pain Undergoing Opioid Tapering

Pain Medicine

Volumn 11, Issue 11, 2010, Pages 1587-1598

  Hooten, W Michael ^a,b   Mantilla, Carlos B ^b   Sandroni, Paola ^c   Townsend, Cynthia O ^b  

^a Departments of Anesthesiology   (United States)

^b Departments of Psychiatry and Psychology   (United States)

^c Mayo Clinic   (United States)

Author keywords

Hyperalgesia; Opioid; Quantitative Sensory Testing

Indexed keywords

MORPHINE; OPIATE;

ARTICLE; CHRONIC PAIN; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; FEMALE; HEAT PAIN PERCEPTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCICEPTION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; WITHDRAWAL SYNDROME;

EID: 78149236358     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2010.00962.x     Document Type: Article

References (54)

1. Fishbain DA, Cole B, Lewis JE, Gao J, Rosomoff RS. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med 2009;10:829-39.
2. Chu LF, Clark DJ, Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain 2006;7:43-8.
3. Doverty M, White JM, Somogyi AA, et al. Hyperalgesic responses in methadone maintenance patients. Pain 2001;90:91-6.
4. Compton P, Charuvastra VC, Kintaudi K, Ling W. Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage 2000;20:237-45.
5. Compton P, Charuvastra VC, Ling W. Pain intolerance in opioid-maintained former opiate addicts: Effect of long-acting maintenance agent. Drug Alcohol Depend 2001;63:139-46.
6. Chen L, Malarick C, Seefeld L, et al. Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain 2009;143:65-70.
7. Younger J, Barelka P, Carroll I, et al. Reduced cold pain tolerance in chronic pain patients following opioid detoxification. Pain Med 2008;9:1158-63.
8. Wang AK, Gillen DA, Dyck PJ. Effect of simple analgesics on quantitative sensation test threshold. Neurology 1999;53:1865-7.
9. Hooten WM, Townsend CO, Sletten CD, Bruce BK, Rome JD. Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med 2007;8:8-16.
10. Bruce BK, Townsend CO, Hooten WM, et al. Chronic pain rehabilitation in chronic headache disorders. Curr Neurol Neurosci Rep 2008;8:94-9.
11. Townsend CO, Bruce BK, Hooten WM, Rome JD. The role of mental health professionals in multidisciplinary pain rehabilitation programs. J Clin Psychol 2006;62:1433-43.
12. Townsend CO, Kerkvliet JL, Bruce BK, et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Pain 2008;140:177-89.
13. Townsend CO, Sletten CD, Bruce BK, et al. Physical and emotional functioning of adult patients with chronic abdominal pain: Comparison with patients with chronic back pain. J Pain 2005;6:75-83.
14. Hooten WM, Townsend CO, Bruce BK, Warner DO. The effects of smoking status on opioid tapering among patients with chronic pain. Anesth Analg 2009;108:308-15.
15. Hooten WM, Townsend CO, Bruce BK, Shi Y, Warner DO. Sex differences in characteristics of smokers with chronic pain undergoing multidisciplinary pain rehabilitation. Pain Med 2009;10:1416-25.
16. Rome JD, Townsend CO, Bruce BK, et al. Chronic noncancer pain rehabilitation with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Mayo Clin Proc 2004;79:759-68.
17. Crisostomo RA, Schmidt JE, Hooten WM, et al. Withdrawal of analgesic medication for chronic low-back pain patients: Improvement in outcomes of multidisciplinary rehabilitation regardless of surgical history. Am J Phys Med Rehabil 2008;87:527-36.
18. Cunningham JL, Rome JD, Kerkvliet JL, Townsend CO. Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: A prospective analysis of admission, discharge, and 6-month follow-up medication costs. Pain Med 2009;10:787-96.
19. Dyck PJ, Zimmerman IR, O'Brien PC, et al. Introduction of automated systems to evaluate touch-pressure, vibration, and thermal cutaneous sensation in man. Ann Neurol 1978;4:502-10.
20. Dyck PJ, Zimmerman I, Gillen DA, et al. Cool, warm, and heat-pain detection thresholds: Testing methods and inferences about anatomic distribution of receptors. Neurology 1993;43:1500-8.
21. Dyck PJ, Zimmerman IR, Johnson DM, et al. A standard test of heat-pain responses using CASE IV. J Neurol Sci 1996;136:54-63.
22. Hooten WM, Sandroni P, Mantilla CB, Townsend CO. Associations between heat pain perception and pain severity among patients with chronic pain. Pain Med 2010 (in press).
23. O'Brien PC, Dyck PJ. Procedures for setting normal values. Neurology 1995;45:17-23.
24. Dyck PJ, O'Brien PC, Litchy WJ, Harper CM, Daube JR. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve 2001;24:307-10.
25. Dyck PJ, O'Brien PC, Johnson DM, Klein CJ, Dyck PJB. Quantitative sensation testing. In: Dyck PJ, ed. Peripheral Nerve. New York: Oxford Press; 2004:1063-93.
26. Dyck PJ, O'Brien PC, Johnson DM, Klein CJ, Dyck PJB. Quantitative sensation testing. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy. Philadelphia, PA: Elsevier Saunders; 2005:1063-93.
27. Dyck PJ, Litchy WJ, Lehman KA, et al. Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology 1995;45:1115-21.
28. DuPen S, DuPen A. Opioid Conversion Calculator [Computer Program]. Poulsbo, WA: Cynergy Group; 2000.
29. Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs 2003;35:253-9.
30. Tompkins DA, Bigelow GE, Harrison JA, et al. Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument. Drug Alcohol Depend 2009;105:154-9.
31. Substance Abuse and Mental Health Services Administration. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville, MD: United States Department of Health and Human Services; 2004.
32. Kerns RD, Turk DC, Rudy TE. The West Haven-Yale Multidimensional Pain Inventory (WHYMPI). Pain 1985;23:345-56.
33. Bernstein IH, Jaremko ME, Hinkley BS. On the utility of the West Haven-Yale Multidimensional Pain Inventory. Spine 1995;20:956-63.
34. Rudy TE. Multiaxial Assessment of Multidimensional Pain Inventory: Computer Program User's Manual [Computer Program]. Pittsburgh, PA: University of Pittsburgh; 1989.
35. Hooten WM, Townsend CO, Decker PA. Gender differences among patients with fibromyalgia undergoing multidisciplinary pain rehabilitation. Pain Med 2007;8:624-32.
36. Hooten WM, Townsend CO, Bruce BK, et al. Effects of smoking status on immediate treatment outcomes of multidisciplinary pain rehabilitation. Pain Med 2009;10:347-55.
37. Dyck PJ, Larson TS, O'Brien PC, Velosa JA. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: A study of three cohorts. Nerve growth factor study group. Diabetes Care 2000;23:510-7.
38. Angst MS, Clark JD. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology 2006;104:570-87.
39. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain 2008;24:479-96.
40. Zhao M, Joo DT. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Anesthesiology 2008;109:308-17.
41. Marie N, Aguila B, Allouche S. Tracking the opioid receptors on the way of desensitization. Cell Signal 2006;18:1815-33.
42. Walk D, Sehgal N, Moeller-Bertram T, et al. Quantitative sensory testing and mapping: A review of nonautomated quantitative methods for examination of the patient with neuropathic pain. Clin J Pain 2009;25:632-40.
43. Shy ME, Frohman EM, So YT, et al. Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;60:898-904.
44. Chong PS, Cros DP. Technology literature review: Quantitative sensory testing. Muscle Nerve 2004;29:734-47.
45. Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. Pain 2006;123:231-43.
46. Peltier A, Smith AG, Russell JW, et al. Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation. Muscle Nerve 2009;39:529-35.
47. Wasner GL, Brock JA. Determinants of thermal pain thresholds in normal subjects. Clin Neurophysiol 2008;119:2389-95.
48. Rolke R, Magerl W, Campbell KA, et al. Quantitative sensory testing: A comprehensive protocol for clinical trials. Eur J Pain 2006;10:77-88.
49. Backonja MM, Walk D, Edwards RR, et al. Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities. Clin J Pain 2009;25:641-7.
50. Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003;106:49-57.
51. Hood DD, Curry R, Eisenach JC. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia. Anesth Analg 2003;97:810-5.
52. Pud D, Cohen D, Lawental E, Eisenberg E. Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 2006;82:218-23.
53. Compton MA. Cold-pressor pain tolerance in opiate and cocaine abusers: Correlates of drug type and use status. J Pain Symptom Manage 1994;9:462-73.
54. Watkins EA, Wollan PC, Melton LJ, 3rd, Yawn BP. A population in pain: Report from the Olmsted County health study. Pain Med 2008;9:166-74.